Clinical trial
High-Dose Chemotherapy Compared With Standard Chemotherapy in Treating Patients…
NCT00004921 · EBMT Solid Tumors Working Party, Other · Completed
Key facts
| NCT number | NCT00004921 |
|---|---|
| Title | High-Dose Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer That Has Been Removed During Surgery |
| Official title | A Randomized Phase III Trial of Sequential High Dose Chemotherapy or Standard Chemotherapy for Optimally Debulked FIGO Stage III and IV Ovarian Cancer |
| Lead sponsor | EBMT Solid Tumors Working Party, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Ovarian Cancer |
| Intervention type | Biological, Drug, Procedure |
| Interventions | filgrastim, carboplatin, cyclophosphamide, melphalan, paclitaxel, adjuvant therapy, bone marrow ablation with stem cell support, peripheral blood stem cell transplantation |
| Start date | Sep 1, 1998 |
| Completion | Sep 1, 2007 |
| First posted | Jan 27, 2003 |
| Last update posted | Sep 17, 2013 |
| Countries | Austria, Belgium, Czechia, Germany, Italy, Slovakia, Spain, Switzerland, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: